S&P Global Ratings Cuts Credit Rating on Embecta (EMBC) After Revenue Decline

Embecta Corp. (NYSE:EMBC) is included among the 12 Best Micro-Cap Dividend Stocks to Buy Now.

S&P Global Ratings Cuts Credit Rating on Embecta (EMBC) After Revenue Decline

On May 12, S&P Global Ratings lowered its issuer credit rating on Embecta Corp. (NYSE:EMBC) to ‘B’ from ‘B+’. The agency pointed to weaker operating performance, increasing competitive pressure, and softer-than-expected fiscal 2026 guidance. It also downgraded the company’s senior secured notes.

S&P Global Ratings said Embecta’s fiscal second-quarter 2026 revenue declined 14%. The drop was mainly tied to weaker demand for pen needles, which remain the company’s core product. The agency also noted that Embecta lost market share to a lower-cost competitor at one of its major customers.

According to the ratings firm, revenue is expected to remain under pressure over the next several years because of continued demand weakness and pricing erosion. The agency also said Embecta’s updated 2026 revenue and operating margin guidance came in below its earlier expectations. S&P Global Ratings believes this could push adjusted leverage above 4x this year, moving beyond its ratings threshold.

Despite the downgrade, the stable outlook reflects expectations that the company will keep leverage below 5x over the next couple of years as it continues using a portion of its free cash flow to reduce debt.

Embecta Corp. (NYSE:EMBC) is a global medical device company focused on improving the health and well-being of people living with diabetes. Its product portfolio includes pen needles, syringes, and safety injection devices.

While we acknowledge the risk and potential of EMBC as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than EMBC and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 14 Best Dividend Stocks to Buy for Steady Growth and 10 Best Robinhood Stocks to Buy According to Billionaires.

Disclosure: None. Follow Insider Monkey on Google News.